 ORIC Pharmaceuticals NASDAQ: ORIC stock is rocketing higher after the company revealed a collaboration deal with Pfizer NYSE: PFE . The big news here is ORIC Pharmaceuticals and Pfizer working together on the development of ORIC-533. 